Join Mike O’Mara, COO of Cellipont Bioservices, and Marcia Blackmoore, VP of Customer Operations at L7 Informatics, for a ...

Board Certified in Endocrinology, Diabetes, and Metabolism and Internal Medicine, Dr. Caveney leads IQVIA’s Obesity, ...

Suanfarma, a global company specializing in the development, production, and commercialization of active pharmaceutical ingredients (APIs) and high-value CDMO services for the health industry, has ...

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s policy shift.

Carbogen Amcis’ Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s NMPA.

The company has expanded its laboratories in the Virginia Biotechnology Research Park in Richmond, Virginia, by acquiring additional analytical capabilities, including advanced spectroscopy tools and ...

The agreement is valued at over $3 billion and increases U.S. manufacturing capacity to help ensure patient access to ...

Jazz Pharmaceuticals has acquired Chimerix Inc. for approximately $935 million in cash. Chimerix is now a wholly owned subsidiary of Jazz.

BigHat Biosciences, a biotechnology company, has entered a strategic collaboration with Eli Lilly and Company.

The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) to treat adults and ...

Leveraging wearable and biometric technology to enhance compliance, boost efficiency, and improve workforce productivity in ...

Incretin mimetics administered by auto-injectors or pens enable significant weight reduction and offer an important means of ...